“Triple Therapy” Rather Than “Triple Threat”
- 1 February 2011
- Vol. 139 (2) , 260-270
- https://doi.org/10.1378/chest.09-3083
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevationEuropean Heart Journal, 2008
- Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant TherapyThe American Journal of Cardiology, 2008
- Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral AnticoagulationJACC: Cardiovascular Interventions, 2008
- Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and PrognosisJournal of the American College of Cardiology, 2008
- Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: Physician practice in the CRUSADE registryAmerican Heart Journal, 2007
- Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stentingEuropean Heart Journal, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulationAmerican Heart Journal, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986